Helliwell, Philip
Coates, Laura C.
FitzGerald, Oliver
Nash, Peter
Soriano, Enrique R.
Elaine Husni, M.
Hsu, Ming-Ann
Kanik, Keith S.
Hendrikx, Thijs
Wu, Joseph
Kudlacz, Elizabeth
Funding for this research was provided by:
Pfizer Inc (N/A)
Article History
Received: 30 May 2018
Accepted: 2 October 2018
First Online: 29 October 2018
Ethics approval and consent to participate
: Studies were conducted in accordance with the International Conference on Harmonisation and Declaration of Helsinki. Study protocols and documentation were approved by the institutional review board or independent ethics committee at each investigational site.
: Not applicable.
: PH has received research grants from AbbVie, Janssen, and Pfizer Inc and has received personal fees from AbbVie, Amgen, Janssen, Pfizer Inc, and UCB. LCC has received research grants from AbbVie, Celgene, Janssen, Novartis, and Pfizer Inc and has received personal fees from AbbVie, Amgen, BMS, Celgene, Galapagos, Janssen, Lilly, MSD, Novartis, Pfizer Inc, Prothena, and UCB. OF has received grants from AbbVie, BMS, and Pfizer Inc and has received personal fees from BMS, Celgene, Janssen, Novartis, Pfizer Inc, and UCB. PN has received grants or fees for participating as a speaker or in advisory boards from AbbVie, BMS, Janssen, Lilly, MSD, Novartis, Pfizer Inc, Roche, Sanofi, and UCB. ERS has received grants or personal fees for participating as speaker or in advisory boards from AbbVie, BMS, GlaxoSmithKline, Janssen, Lilly, Novartis, Pfizer Inc, Roche, Sandoz, and UCB. MEH has received consultant or personal fees for participating in advisory boards from AbbVie, Genzyme/Sanofi, Janssen, Lilly, Novartis, and UCB. MAH, KSK, TH, JW, and EK are employees of Pfizer Inc and hold stock/stock options in Pfizer Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.